Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 17;12(20):e030511.
doi: 10.1161/JAHA.123.030511. Epub 2023 Oct 10.

Iodine-Induced Hypothyroidism and Long-Term Risks of Incident Heart Failure

Affiliations

Iodine-Induced Hypothyroidism and Long-Term Risks of Incident Heart Failure

Kosuke Inoue et al. J Am Heart Assoc. .

Abstract

Background Although most individuals can adapt to a large iodine load and remain euthyroid, hypothyroidism can develop after iodine exposure. Hypothyroidism is associated with adverse cardiovascular consequences, including heart failure. This study was performed to investigate the relationships between iodine-induced hypothyroidism and incident heart failure. Methods and Results This cohort study of the US Veterans Health Administration (1998-2021) included adults aged ≥18 years with a serum thyroid-stimulating hormone (thyrotropin) <60 days of iodine contrast administration, and <1 year of a baseline normal serum thyroid-stimulating hormone. Cox proportional hazards regression ascertained risk of incident heart failure following iodine-induced hypothyroidism, adjusting for age, sex, race and ethnicity, body mass index, and history of coronary heart disease, dyslipidemia, diabetes, and hypertension. Of 45 470 veterans (mean±SD age, 61.1±14.1 years; 88% men), 3361 (7.4%) developed iodine-induced hypothyroidism. Heart failure developed in 5685 (12.5%) individuals over a median follow-up of 3.6 years (interquartile range, 1.9-7.2 years). Adjusted for risk factors, iodine-induced hypothyroidism was associated with increased risk of heart failure, compared with those who remained euthyroid after iodine exposure (adjusted hazard ratio [HR], 1.11 [95% CI, 1.01-1.22]). Women were at greater risk than men (adjusted HR: women, 1.65 [95% CI, 1.13-2.40]; men, 1.08 [95% CI, 0.98-1.19]; P for interaction, 0.02). Conclusions In the largest US study of this topic, hypothyroidism following iodine exposure was associated with an increased risk of incident heart failure, particularly in women. These findings support the need for further research to address the clinical significance of this issue, including the possible sex-specific risks of incident heart failure in more diverse data sets and study populations.

Keywords: heart failure; hypothyroidism; iodine; thyroid dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow of study sample selection.
T3 indicates triiodothyronine; T4, thyroxine; TSH, thyroid‐stimulating hormone; and VHA, Veterans Health Administration.
Figure 2
Figure 2. Cumulative incidence of heart failure (HF) according to thyroid function (euthyroid vs hypothyroid) following iodine exposure.
The adjusted hazard ratio (aHR) was calculated by Cox proportional hazard models adjusting for age, sex, race and ethnicity, body mass index, and history of coronary heart disease, diabetes, dyslipidemia, and hypertension. Inverse probability weight obtained used these variables was applied to draw the adjusted incidence curve. Overall hypothyroidism after a previously normal baseline thyroid‐stimulating hormone and iodine administration was associated with an increased risk of heart failure (aHR, 1.11 [95% CI, 1.01–1.22]). The E‐value for the point estimate (and the lower bound of 95% CI) was 1.46 (1.11).
Figure 3
Figure 3. Associations between hypothyroidism and risk of heart failure by age, sex, and race and ethnicity.
Model adjusted for age, sex, race and ethnicity, body mass index, and history of coronary heart disease, diabetes, dyslipidemia, and hypertension. HR indicates hazard ratio.

References

    1. Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A review: radiographic iodinated contrast media‐induced thyroid dysfunction. J Clin Endocrinol Metab. 2015;100:376–383. doi: 10.1210/jc.2014-3292 - DOI - PMC - PubMed
    1. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10:136–142. doi: 10.1038/nrendo.2013.251 - DOI - PMC - PubMed
    1. Inoue K, Guo R, Lee ML, Ebrahimi R, Neverova NV, Currier JW, Bashir MT, Leung AM. Iodinated contrast administration and risks of thyroid dysfunction: a retrospective cohort analysis of the U.S. Veterans Health Administration system. Thyroid. 2023;33:230–238. doi: 10.1089/thy.2022.0393 - DOI - PubMed
    1. Klein I, Danzi S. Thyroid disease and the heart. Curr Probl Cardiol. 2016;41:65–92. doi: 10.1016/j.cpcardiol.2015.04.002 - DOI - PubMed
    1. Willard DL, Leung AM, Pearce EN. Thyroid function testing in patients with newly diagnosed hyperlipidemia. JAMA Int Med. 2014;174:287–289. doi: 10.1001/jamainternmed.2013.12188 - DOI - PMC - PubMed

Publication types